$AUGG
AUGUSTA GOLD CORP. Stock $augg

$augg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000121390023037332 Filed on May 08, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.217M	$1.316M	$1.068M
YoY Change	-1.86%	23.19%	-20.31%
% of Gross Profit
Research & Development	$626.4K	$724.3K	$338.6K
YoY Change	-57.72%	113.88%	-86.87%
% of Gross Profit
Depreciation & Amortization	$11.02K	$11.01K	$11.01K
YoY Change	0.0%	0.04%	10.1%
% of Gross Profit
Operating Expenses	$1.880M	$2.079M	$1.425M
YoY Change	-31.69%	45.92%	-63.84%
Operating Profit	-$1.880M	-$2.079M	-$1.425M
YoY Change	-31.69%	45.92%
Interest Expense	$631.1K	$626.7K	$209.6K
YoY Change	-366.48%	198.99%	4.81%
% of Operating Profit
Other Income/Expense, Net	$5.338M	$8.223M	-$206.2K
YoY Change	-217.02%	-4088.26%	-97.06%
Pretax Income	$2.877M	$5.446M	-$1.421M
YoY Change	-138.11%	-483.19%	-86.78%
Income Tax
% Of Pretax Income
Net Earnings	$2.877M	$5.446M	-$1.421M
YoY Change	-138.11%	-483.19%	-86.78%
Net Earnings / Revenue
Basic Earnings Per Share	$0.03	$0.06	-$0.02
Diluted Earnings Per Share	$0.03	$0.06	-$20.15K
COMMON SHARES
Basic Shares Outstanding	85.96M shares	85.93M shares	70.52M shares
Diluted Shares Outstanding	85.99M shares	84.66M shares	70.52M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.043M	$3.591M	$19.02M
YoY Change	-59.49%	-81.13%	-27.88%
Cash & Equivalents	$2.043M	$3.591M	$19.02M
Short-Term Investments
Other Short-Term Assets	$195.9K	$210.6K	$141.3K
YoY Change	104.72%	49.0%	-25.62%
Inventory
Prepaid Expenses	$188.9K	$203.5K
Receivables
Other Receivables
Total Short-Term Assets	$2.239M	$3.801M	$19.17M
YoY Change	-56.43%	-80.17%	-27.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.066M	$1.077M	$12.48M
YoY Change	-3.97%	-91.37%	3.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.116M	$1.116M
YoY Change
Total Long-Term Assets	$61.14M	$61.16M	$12.48M
YoY Change	2.29%	389.99%	3.15%
TOTAL ASSETS
Total Short-Term Assets	$2.239M	$3.801M	$19.17M
Total Long-Term Assets	$61.14M	$61.16M	$12.48M
Total Assets	$63.38M	$64.96M	$31.65M
YoY Change	-2.36%	105.26%	-18.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.070M	$1.012M	$461.4K
YoY Change	-11.33%	119.24%	-58.43%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$24.10M	$23.47M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$25.28M	$25.53M	$1.501M
YoY Change	3.95%	1600.79%	35.24%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$6.373M	$10.82M	$8.888M
YoY Change	-56.37%	21.71%	-72.58%
Total Long-Term Liabilities	$6.373M	$10.82M	$8.888M
YoY Change	-56.37%	21.71%	-72.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.28M	$25.53M	$1.501M
Total Long-Term Liabilities	$6.373M	$10.82M	$8.888M
Total Liabilities	$31.65M	$36.35M	$10.39M
YoY Change	-18.69%	249.87%	-69.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$31.57M	-$34.45M
YoY Change	8.33%
Common Stock	$8.593K	$8.593K
YoY Change	8.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.73M	$28.61M	$21.26M
YoY Change
Total Liabilities & Shareholders Equity	$63.38M	$64.96M	$31.65M
YoY Change	-2.36%	105.26%	-18.16%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$2.877M	$5.446M	-$1.421M
YoY Change	-138.11%	-483.19%	-86.78%
Depreciation, Depletion And Amortization	$11.02K	$11.01K	$11.01K
YoY Change	0.0%	0.04%	10.1%
Cash From Operating Activities	-$1.547M	-$3.494M	-$557.3K
YoY Change	-9.56%	526.9%	-80.17%
INVESTING ACTIVITIES
Capital Expenditures	$0.00		$0.00
YoY Change	-100.0%		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00		$0.00
YoY Change	-100.0%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$6.752M	0.000
YoY Change	-100.0%		-100.0%
NET CHANGE
Cash From Operating Activities	-1.547M	-$3.494M	-557.3K
Cash From Investing Activities	0.000		0.000
Cash From Financing Activities	0.000	$6.752M	0.000
Net Change In Cash	-1.547M	$3.258M	-557.3K
YoY Change	-88.93%	-684.61%	-104.63%
FREE CASH FLOW
Cash From Operating Activities	-$1.547M	-$3.494M	-$557.3K
Capital Expenditures	$0.00		$0.00
Free Cash Flow	-$1.547M		-$557.3K
YoY Change	-114.26%		-77.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	85959753	shares
CY2022Q1	augg	Mineral Properties Net Current MineralPropertiesNetCurrent	1039786	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3590769	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	332813	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	203546	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	156959	usd
CY2023Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	0	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	121424	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	7028	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	7028	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	3801343	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	618224	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1077435	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1088449	usd
CY2023Q1	augg	Reclamation Bonds ReclamationBonds	1115813	usd
CY2022Q4	augg	Reclamation Bonds ReclamationBonds	0	usd
CY2023Q1	us-gaap	Mineral Properties Net MineralPropertiesNet	58962286	usd
CY2022Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	58962286	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	61155534	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	60050735	usd
CY2023Q1	us-gaap	Assets Assets	64956877	usd
CY2022Q4	us-gaap	Assets Assets	60668959	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1011613	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2906285	usd
CY2023Q1	augg	Deferred Acquisition Liability DeferredAcquisitionLiability	23470037	usd
CY2022Q4	augg	Deferred Acquisition Liability DeferredAcquisitionLiability	22843322	usd
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Vancouver
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	BC
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	V6C 3E1
CY2023Q1	dei	City Area Code CityAreaCode	(604)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	687-1717
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-54653
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	AUGUSTA GOLD CORP.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-2252162
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	Suite 555 - 999 Canada Place
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	1050400	usd
CY2023Q1	augg	Mineral Properties Net Long Term MineralPropertiesNetLongTerm	1756932	usd
CY2022Q1	augg	Mineral Properties Net Long Term MineralPropertiesNetLongTerm	921441	usd
CY2022Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	1009496	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	25532050	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	26759103	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1756932	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1804939	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	9060690	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	15615406	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	10817622	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	17420345	usd
CY2023Q1	us-gaap	Liabilities Liabilities	36349672	usd
CY2022Q4	us-gaap	Liabilities Liabilities	44179448	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	augg	Preferred Stock Value One PreferredStockValueOne	0	usd
CY2022Q4	augg	Preferred Stock Value One PreferredStockValueOne	0	usd
CY2023Q1	augg	Preferred Stock Value Two PreferredStockValueTwo	0	usd
CY2022Q4	augg	Preferred Stock Value Two PreferredStockValueTwo	0	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85929753	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	85929753	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79204606	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79204606	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	8593	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	7920	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	63046407	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56375344	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34447795	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39893753	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28607205	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16489511	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64956877	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60668959	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1315572	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1067879	usd
CY2023Q1	us-gaap	Exploration Expense ExplorationExpense	724270	usd
CY2022Q1	us-gaap	Exploration Expense ExplorationExpense	338639	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	27907	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	7099	usd
CY2023Q1	us-gaap	Depreciation Depreciation	11014	usd
CY2022Q1	us-gaap	Depreciation Depreciation	11014	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2078763	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1424631	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	177361	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2078763	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1424631	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8223387	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206193	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	626715	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-71951	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	209611	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5445958	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1421213	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84435276	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70519188	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84660278	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70519188	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	22239747	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	438522	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1421213	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	21257056	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16489511	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	472981	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7867426	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1668671	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5445958	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	28607205	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5445958	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1421213	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	27907	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	7099	usd
CY2023Q1	us-gaap	Depreciation Depreciation	11014	usd
CY2022Q1	us-gaap	Depreciation Depreciation	11014	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8223387	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	206193	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	472981	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	438522	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	46587	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-58753	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-121424	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	usd
CY2023Q1	augg	Increase Decrease Debt Issuance Costs IncreaseDecreaseDebtIssuanceCosts	-37401	usd
CY2022Q1	augg	Increase Decrease Debt Issuance Costs IncreaseDecreaseDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1894673	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	589315	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	0	usd
CY2023Q1	augg	Working Capital Deficiency WorkingCapitalDeficiency	21700000	usd
CY2023Q1	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	-35010	usd
CY2022Q1	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	-35014	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3493657	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-557285	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8568651	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	701225	usd
CY2023Q1	augg	Increase In Surety Bond Collateral IncreaseInSuretyBondCollateral	1115813	usd
CY2022Q1	augg	Increase In Surety Bond Collateral IncreaseInSuretyBondCollateral	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6751613	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3257956	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-557285	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	332813	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19581707	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3590769	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19024422	usd
CY2023Q1	us-gaap	Interest Paid InterestPaid	0	usd
CY2022Q1	us-gaap	Interest Paid InterestPaid	0	usd
CY2023Q1	augg	Revaluation Of Asset Retirement Obligation RevaluationOfAssetRetirementObligation	0	usd
CY2022Q1	augg	Revaluation Of Asset Retirement Obligation RevaluationOfAssetRetirementObligation	120877	usd
CY2023Q1	augg	Warrant Liability From Units Placement WarrantLiabilityFromUnitsPlacement	1668671	usd
CY2022Q1	augg	Warrant Liability From Units Placement WarrantLiabilityFromUnitsPlacement	0	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	7099	usd
CY2023Q1	augg	Acquisition Of Cr Reward Asset Retirement And Environmental Obligations AcquisitionOfCRRewardAssetRetirementAndEnvironmentalObligations	-18343	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3600000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span><b><span style="text-decoration:underline">Use of Estimates</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates have been made for share-based compensation, asset retirement obligation, warrant liability and whether acquisitions of Bullfrog Mines and CR Reward constituted an asset acquisitions or business combinations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; "> </p>
CY2023Q1	us-gaap	Mineral Properties Gross MineralPropertiesGross	2814435	usd
CY2022Q1	us-gaap	Mineral Properties Gross MineralPropertiesGross	1868265	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	27907	usd
CY2022Q1	augg	Acquisition Of Cr Reward Asset Retirement And Environmental Obligations AcquisitionOfCRRewardAssetRetirementAndEnvironmentalObligations	-35014	usd
CY2023Q1	augg	Change In Estimates ChangeInEstimates	-16667	usd
CY2022Q1	augg	Change In Estimates ChangeInEstimates	120877	usd
CY2023Q1	augg	Mineral Properties Net Current MineralPropertiesNetCurrent	1050400	usd
CY2023Q1	augg	Cash Reclamation Bonds CashReclamationBonds	1115813	usd
CY2023Q1	augg	Life Of Mine LifeOfMine	2028
CY2022Q1	augg	Life Of Mine LifeOfMine	2028
CY2023Q1	augg	Discount Rate DiscountRate	0.036	pure
CY2022Q1	augg	Discount Rate DiscountRate	0.024	pure
CY2023Q1	augg	Inflation Rate InflationRate	0.022	pure
CY2022Q1	augg	Inflation Rate InflationRate	0.02	pure
CY2023Q1	augg	Cash Flows Rate CashFlowsRate	0.036	pure
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	5445958	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1421213	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84435276	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	70519188	shares
CY2023Q1	augg	Assumed Conversion Of Dilutive Shares AssumedConversionOfDilutiveShares	225002	shares
CY2022Q1	augg	Assumed Conversion Of Dilutive Shares AssumedConversionOfDilutiveShares	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	84660278	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70519188	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	39901617	shares
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12415715	usd
CY2022	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	47723766	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60139481	usd
CY2023Q1	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	0	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60139481	usd
CY2021Q4	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	44689	usd
CY2022Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	44057	usd
CY2022Q4	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	88746	usd
CY2023Q1	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	11014	usd
CY2023Q1	us-gaap	Property Plant And Equipment Owned Gross PropertyPlantAndEquipmentOwnedGross	99760	usd
CY2023Q1	us-gaap	Derivative Assets Liabilities At Fair Value Net DerivativeAssetsLiabilitiesAtFairValueNet	60039721	usd
CY2020Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	9100000	shares
CY2020Q4	augg	Stock Option Exercise Price Decreases StockOptionExercisePriceDecreases	1.8
CY2020Q4	augg	Royalty Percentage RoyaltyPercentage	0.02	pure
CY2020Q4	augg	Royalty Deed Description RoyaltyDeedDescription	Pursuant to the Royalty Deed, the Barrick Royalty is reduced to the extent necessary so that royalties burdening any individual parcel or claim included in the Barrick Properties on October 26, 2020, inclusive of the Barrick Royalty, would not exceed 5.5% in the aggregate, provided that the Barrick Royalty in respect of any parcel or claim would not be less than 0.5%, even if the royalties burdening a parcel or claim included in the Barrick Properties would exceed 5.5%.
CY2022Q2	augg	Initial Payment Shares Description InitialPaymentSharesDescription	$12,500,000 in cash paid at the closing; plus (b) the issuance of 7,800,000 shares of Augusta Gold common stock at closing; plus (c) $22,126,000 in cash paid on September 14, 2022 (comprising collectively the “Second Payment” and the “Deferred Payment”).
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1299	usd
CY2023Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	9658	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	838992	usd
CY2023Q1	us-gaap	Mineral Properties Accumulated Impairment MineralPropertiesAccumulatedImpairment	46465056	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	10500	usd
CY2023Q1	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1100434	usd
CY2023Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	46204071	usd
CY2023Q1	augg	Total Coverage Amount TotalCoverageAmount	3188036	usd
CY2023Q1	us-gaap	Partners Capital Account Units Sold In Public Offering PartnersCapitalAccountUnitsSoldInPublicOffering	6725147	shares
CY2023Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1.71
CY2023Q1	us-gaap	Sale Leaseback Transaction Gross Proceeds Investing Activities SaleLeasebackTransactionGrossProceedsInvestingActivities	11500000	cad
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	3362573	shares
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Cash Awards Granted Percentage DeferredCompensationArrangementWithIndividualCashAwardsGrantedPercentage	0.05	pure
CY2023Q1	us-gaap	Stock Dividends Shares StockDividendsShares	336257	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.71
CY2011Q3	augg	Shareholder In Percentage ShareholderInPercentage	0.0499	pure
CY2011Q3	augg	Prior Notice In Percentage PriorNoticeInPercentage	0.0999	pure
CY2023Q1	augg	Public Conversion Percentage PublicConversionPercentage	0.0499	pure
CY2022Q2	augg	Outstanding Shares OutstandingShares	677084	shares
CY2021Q1	augg	Common Stock Percenatage CommonStockPercenatage	0.10	pure
CY2022Q2	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	324816	usd
CY2022Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	99021	usd
CY2022Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	4541667	shares
CY2022Q3	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	3
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	480250	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	188233	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	292017	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	472981	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	438522	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4800002	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.55
CY2021Q4	augg	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	P4Y4M9D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	29817	usd
CY2022	augg	Number Of Options Exercised NumberOfOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	augg	Weighted Average Remaining Contractual Life Years Exercised WeightedAverageRemainingContractualLifeYearsExercised	P0Y
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	augg	Number Of Options Issued NumberOfOptionsIssued	450000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.03
CY2022	augg	Weighted Average Remaining Contractual Life Years Issued WeightedAverageRemainingContractualLifeYearsIssued	P5Y
CY2022	augg	Aggregate Intrinsic Value Issued AggregateIntrinsicValueIssued	0	usd
CY2022	augg	Number Of Options Canceled NumberOfOptionsCanceled	50000	shares
CY2022	augg	Weighted Average Exercise Price Canceled WeightedAverageExercisePriceCanceled	2
CY2022	augg	Weighted Average Remaining Contractual Life Years Canceled WeightedAverageRemainingContractualLifeYearsCanceled	P0Y
CY2022	augg	Aggregate Intrinsic Value Canceled AggregateIntrinsicValueCanceled	0	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5200002	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.56
CY2022Q4	augg	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	P3Y5M12D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	57468	usd
CY2023Q1	augg	Number Of Options Exercised NumberOfOptionsExercised	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	augg	Weighted Average Remaining Contractual Life Years Exercised WeightedAverageRemainingContractualLifeYearsExercised	P0Y
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	augg	Number Of Options Issued NumberOfOptionsIssued	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	augg	Weighted Average Remaining Contractual Life Years Issued WeightedAverageRemainingContractualLifeYearsIssued	P0Y
CY2023Q1	augg	Aggregate Intrinsic Value Issued AggregateIntrinsicValueIssued	0	usd
CY2023Q1	augg	Number Of Options Canceled NumberOfOptionsCanceled	0	shares
CY2023Q1	augg	Weighted Average Exercise Price Canceled WeightedAverageExercisePriceCanceled	0
CY2023Q1	augg	Weighted Average Remaining Contractual Life Years Canceled WeightedAverageRemainingContractualLifeYearsCanceled	P0Y
CY2023Q1	augg	Aggregate Intrinsic Value Canceled AggregateIntrinsicValueCanceled	0	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5200002	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.56
CY2023Q1	augg	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	P3Y1M13D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	15985	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3658335	shares
CY2023Q1	augg	Weighted Average Exercise Price Options Exercisable WeightedAverageExercisePriceOptionsExercisable	1.54
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P3Y3M21D
CY2023Q1	augg	Aggregate Intrinsic Value Options Exercisable AggregateIntrinsicValueOptionsExercisable	15985	usd
CY2023Q1	us-gaap	Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma	34701615	shares
CY2021	augg	Warrants Issuedincludes Expired Warrants WarrantsIssuedincludesExpiredWarrants	36344471	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	31427195	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	208334	shares
CY2022	augg	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrumentswarrantsissued ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentswarrantsissued	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	216076	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	31002785	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2023Q1	augg	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrumentswarrantsissued ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentswarrantsissued	3698830	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	34701615	shares
CY2020Q4	augg	Fair Market Value Of Common Stock FairMarketValueOfCommonStock	1.26
CY2022Q4	augg	Fair Market Value Of Common Stock FairMarketValueOfCommonStock	1.4
CY2023Q1	augg	Fair Market Value Of Common Stock FairMarketValueOfCommonStock	1.09
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.38
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.33
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	1.33
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y9M18D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y7M6D
CY2020Q4	augg	Financial Instruments Volatility Range FinancialInstrumentsVolatilityRange	0.684	pure
CY2022Q4	augg	Financial Instruments Volatility Range FinancialInstrumentsVolatilityRange	1.015	pure
CY2023Q1	augg	Financial Instruments Volatility Range FinancialInstrumentsVolatilityRange	0.821	pure
CY2020Q4	augg	Financila Instruments Riskfree Rate FinancilaInstrumentsRiskfreeRate	0.0018	pure
CY2022Q4	augg	Financila Instruments Riskfree Rate FinancilaInstrumentsRiskfreeRate	0.0441	pure
CY2023Q1	augg	Financila Instruments Riskfree Rate FinancilaInstrumentsRiskfreeRate	0.0406	pure
CY2022Q3	us-gaap	Other Investments OtherInvestments	22232561	usd
CY2023Q1	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.03	pure
CY2023Q1	us-gaap	Property Management Fee Percent Fee PropertyManagementFeePercentFee	0.005	pure
CY2023Q1	us-gaap	Principal Transactions Revenue PrincipalTransactionsRevenue	22232561	usd
CY2023Q1	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	8918	usd
CY2023Q1	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	1246394	usd
CY2023Q1	us-gaap	Loans Payable LoansPayable	23470037	usd
CY2023Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	153306	usd
CY2022Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	88257	usd
CY2023Q1	augg	Relatedpartyoffice Relatedpartyoffice	27228	usd
CY2022Q1	augg	Relatedpartyoffice Relatedpartyoffice	10840	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	50089	usd
CY2022Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	7920	usd
CY2023Q1	augg	Total Related Party Costs1 TotalRelatedPartyCosts1	230623	usd
CY2022Q1	augg	Total Related Party Costs1 TotalRelatedPartyCosts1	107017	usd
CY2023Q1	us-gaap	Payments For Rent PaymentsForRent	183000	usd
CY2023Q1	augg	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	95557	usd
CY2023Q1	augg	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	87594	usd
CY2023Q1	augg	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	183151	usd
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	472981	usd
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	438522	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	39900	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	22400	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2400	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2400	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	2400	usd
CY2023Q1	augg	Operating Leases Future Minimum Payments Due In Six Years OperatingLeasesFutureMinimumPaymentsDueInSixYears	2400	usd
CY2023Q1	augg	Operating Leases Future Minimum Payments Due In Seven Years OperatingLeasesFutureMinimumPaymentsDueInSevenYears	2400	usd
CY2023Q1	augg	Operating Leases Future Minimum Payments Due In Thereafter Seven Years OperatingLeasesFutureMinimumPaymentsDueInThereafterSevenYears	2400	usd
CY2017Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P30Y
CY2017Q3	augg	Number Of Patented Mining NumberOfPatentedMining	24	pure
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79204606	shares
CY2017Q3	us-gaap	Investment Interest Rate InvestmentInterestRate	1	pure
CY2023Q1	us-gaap	Other Commitments Description OtherCommitmentsDescription	Under the Lunar Lease, RMM shall expend as minimum work commitments of $50,000 per year starting in 2017 until a cumulative of $500,000 of expense has been incurred. If RMM fails to perform its obligations under the Lunar Lease, and in particular fails to make any payment due to Lunar thereunder, Lunar may declare RMM in default by giving RMM written notice of default which specifies the obligation(s) which RMM has failed to perform. If RMM fails to remedy a default in payment within fifteen (15) days of receiving the notice of default or fails to remedy or commence to remedy any other default within thirty (30) days of receiving notice, Lunar may terminate the Lunar Lease and RMM shall peaceably surrender possession of the properties to Lunar.
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	111000	usd
CY2023Q1	augg	Leases Future Minimum Payments Due In Four Years LeasesFutureMinimumPaymentsDueInFourYears	21000	usd
CY2023Q1	augg	Leases Future Minimum Payments Due In Five Years LeasesFutureMinimumPaymentsDueInFiveYears	25000	usd
CY2023Q1	augg	Leases Future Minimum Payments Due In Five Years One LeasesFutureMinimumPaymentsDueInFiveYearsOne	30000	usd
CY2023Q1	augg	Leases Future Minimum Payments Due In Five Years Two LeasesFutureMinimumPaymentsDueInFiveYearsTwo	40000	usd
CY2023Q1	augg	Leases Future Minimum Payments Due In Five Years Three LeasesFutureMinimumPaymentsDueInFiveYearsThree	45000	usd
CY2014Q4	augg	Option Agreement Description OptionAgreementDescription	RMM entered into an Option Agreement (the “Mojave Option”) with Mojave Gold Mining Corporation (“Mojave”). Mojave holds the purchase rights to 100% of 12 patented mining claims located in Nye County, Nevada. This property is contiguous to the Company’s Bullfrog Project and covers approximately 156 acres, including the northeast half of the M-S pit mined by Barrick Gold in the 1990s.
CY2023Q1	us-gaap	Public Utilities Property Plant And Equipment Interest Rate On Intermediary Debt For Electric Utility Plant Construction PublicUtilitiesPropertyPlantAndEquipmentInterestRateOnIntermediaryDebtForElectricUtilityPlantConstruction	1	pure
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	160000	usd
CY2023Q1	augg	Remaining Payment RemainingPayment	30000	usd
CY2020Q4	augg	Option Agreement Description OptionAgreementDescription	Bullfrog Mines entered into a mining option agreement with Abitibi Royalties (USA) Inc. (“Abitibi”) granting Bullfrog Mines the option (the “Abitibi Option”) to acquire forty-three unpatented lode mining claims to the south of the Bullfrog deposit. The Abitibi Option was amended on December 9, 2022, to extend the exercise deadline and to increase the last payment amount required to exercise the option. Bullfrog Mines made an initial payment to Abitibi of C$25,000 and exercised the Abitibi Option in full on January 30, 2023. ●Paying to Abitibi C$50,000 in cash before December 9, 2021; ●Paying to Abitibi C$78,750 in cash before January 30, 2023; and ●Granting to Abitibi a 2% net smelter royalty on the claims subject to the Abitibi Option on January 30, 2023, of which Bullfrog Mines has the option to purchase 0.5% for C$500,000 on or before December 9, 2030.
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	250000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	79204606	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85929753	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	85929753	shares
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001448597

Files In Submission

Name	View Source	Status
augg-20230331_lab.xml	Edgar Link	unprocessable
augg-20230331_cal.xml	Edgar Link	unprocessable
augg-20230331_pre.xml	Edgar Link	unprocessable
0001213900-23-037332-index-headers.html	Edgar Link	pending
0001213900-23-037332-index.html	Edgar Link	pending
0001213900-23-037332.txt	Edgar Link	pending
0001213900-23-037332-xbrl.zip	Edgar Link	pending
augg-20230331.xsd	Edgar Link	pending
augg-20230331_def.xml	Edgar Link	unprocessable
f10q0323ex31-1_augusta.htm	Edgar Link	pending
f10q0323ex31-2_augusta.htm	Edgar Link	pending
f10q0323ex32-1_augusta.htm	Edgar Link	pending
f10q0323ex32-2_augusta.htm	Edgar Link	pending
f10q0323_augustagold.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0323_augustagold_htm.xml	Edgar Link	completed
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AUGG
AUGUSTA GOLD CORP. Stock $augg

2023 Q2 Form 10-Q Financial Statement

#000121390023037332 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUGG AUGUSTA GOLD CORP. Stock $augg

2023 Q2 Form 10-Q Financial Statement

#000121390023037332 Filed on May 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AUGG
AUGUSTA GOLD CORP. Stock $augg